home / stock / dplo / dplo news


DPLO News and Press, Diplomat Pharmacy Inc. From 11/26/18

Stock Information

Company Name: Diplomat Pharmacy Inc.
Stock Symbol: DPLO
Market: NYSE

Menu

DPLO DPLO Quote DPLO Short DPLO News DPLO Articles DPLO Message Board
Get DPLO Alerts

News, Short Squeeze, Breakout and More Instantly...

DPLO - Diplomat Switches to Fully Recyclable Packaging for Temperature-Sensitive Medication

FLINT, Mich. , Nov. 26, 2018 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO), is now shipping temperature-sensitive medication in ClimaCell™ coolers from TemperPack. ClimaCell coolers are fully recyclable at curbside and insulated with renewable materials tha...

DPLO - New Research Coverage Highlights Harmonic, ScanSource, Clean Energy Fuels, American Software, Diplomat Pharmacy, and Quidel - Consolidated Revenues, Company Growth, and Expectations for 2018

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc. (NASDAQ:HLIT), ScanSource, Inc. (NASDAQ:SCSC), Clean Ene...

DPLO - Diplomat Pharmacy 2018 Q3 - Results - Earnings Call Slides

The following slide deck was published by Diplomat Pharmacy in conjunction with their 2018 Q3 earnings Read more ...

DPLO - Diplomat Pharmacy down 32% after Q3 revenue miss and 83% drop in earnings

Diplomat Pharmacy ( DPLO -32.1% ) slumps on more than double normal volume following its Q3 report released after the close yesterday that included a revenue miss of $50M. Highlights: More news on: Diplomat Pharmacy, Healthcare stocks news, Earnings news and commentary, Stocks on the m...

DPLO - Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q3 2018 Results - Earnings Call Transcript

Diplomat Pharmacy, Inc. (DPLO) Q3 2018 Results Earnings Conference Call November 06, 2018 05:00 PM ET Executives Terri Anne Powers - VP, IR Brian Griffin - Chairman and CEO Joel Saban - President Atul Kavthekar - CFO Analysts Lisa Gill - JP Morgan Steven Valiquette - Ba...

DPLO - Diplomat Pharmacy EPS in-line, misses on revenue

Diplomat Pharmacy (NYSE: DPLO ): Q3 GAAP EPS of $0.00 in-line. More news on: Diplomat Pharmacy, Earnings news and commentary, Healthcare stocks news, Read more ...

DPLO - Diplomat Announces 3rd Quarter Financial Results

FLINT, Mich. , Nov. 6, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30, 2018 . All comparisons, unless otherwise noted, are to the quar...

DPLO - Notable earnings after Tuesday's close

ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...

DPLO - Diplomat to Release Third-Quarter 2018 Operating Results, Host Conference Call on Nov. 6

FLINT, Mich. , Oct. 16, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its third-quarter 2018 operating results after market close Tuesday, Nov. 6 , with a conference call to follow at 5 p.m. ET . Shareholders and interested participants can listen to...

DPLO - Market Trends Toward New Normal in Diplomat Pharmacy, Senior Housing Properties Trust, FARO Technologies, Endurance International Group, PolyOne, and NorthWestern - Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Diplomat Pharmacy, Inc. (NYSE:DPLO), Senior Housing Properties Trust (...

Previous 10 Next 10